keyword
https://read.qxmd.com/read/38655747/effects-of-cannabidiol-and-%C3%AE-9-tetrahydrocannabinol-on-cytochrome-p450-enzymes-a-systematic-review
#1
REVIEW
Sarah Ann Smith, Gia Han Le, Kayla M Teopiz, Angela T H Kwan, Taeho Greg Rhee, Roger C Ho, Jie Wu, Bing Cao, Felicia Ceban, Roger S McIntyre
Due to legal, political, and cultural changes, the use of cannabis has rapidly increased in recent years. Research has demonstrated that the cannabinoids cannabidiol (CBD) and Δ9 -tetrahydrocannabinol (THC) inhibit and induce cytochrome P450 (CYP450) enzymes. The objective of this review is to evaluate the effect of CBD and THC on the activity of CYP450 enzymes and the implications for drug-drug interactions (DDIs) with psychotropic agents that are CYP substrates. A systematic search was conducted using PubMed, Scopus, Scientific Electronic Library Online (SciELO) and PsychINFO...
April 24, 2024: Drug Metabolism Reviews
https://read.qxmd.com/read/38653646/evaluation-of-an-electronic-prescription-platform-clinicians-feedback-on-three-distinct-services-aiming-to-facilitate-clinical-decision-and-safer-e-prescription
#2
JOURNAL ARTICLE
Margarita Grammatikopoulou, Martha Zachariadou, Maria Zande, Georgios Giannios, Achilleas Chytas, Haralampos Karanikas, Spiros Georgakopoulos, Dimitrios Karanikas, George Nikolaidis, Pantelis Natsiavas, Thanos G Stavropoulos, Spiros Nikolopoulos, Ioannis Kompatsiaris
BACKGROUND: Health Care Professionals (HCPs) are the main end-users of digital clinical tools such as electronic prescription systems. For this reason, it is of high importance to include HCPs throughout the design, development and evaluation of a newly introduced system to ensure its usefulness, as well as confirm that it tends to their needs and can be integrated in their everyday clinical practice. METHODS: In the context of the PrescIT project, an electronic prescription platform with three services was developed (i...
April 17, 2024: Research in Social & Administrative Pharmacy: RSAP
https://read.qxmd.com/read/38651308/antibody-drug-conjugates-design-implications-for-clinicians
#3
REVIEW
Stephanie Pang, Arianne Duong, Chloe Siu, Amy Indorf
OBJECTIVE: There are currently 11 antibody-drug conjugates (ADC) that are FDA approved for use in oncologic disease states, with many more in the pipeline. The authors aim to review the pharmacokinetic profiles of the components of ADCs to engage pharmacist practitioners in practical considerations in the care of patients. This article provides an overview on the use of ADCs in the setting of organ dysfunction, drug-drug interactions, and management of on- and off-target adverse effects...
April 23, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38651025/maternal-substance-use-and-early-life-adversity-inducing-drug-dependence-in-offspring-interactions-mechanisms-and-treatments
#4
REVIEW
Maysam Fadaei-Kenarsary, Khadijeh Esmaeilpour, Mohammad Shabani, Vahid Sheibani
The likelihood of substance dependency in offspring is increased in cases when there is a family history of drug or alcohol use. Mothering is limited by maternal addiction because of the separation. Maternal separation (MS) leads to the development of behavioural and neuropsychiatric issues in the future. Despite the importance of this issue, empirical investigations of the influences of maternal substance use and separation on substance use problems in offspring are limited, and studies that consider both effects are rare...
February 2024: Addiction & Health
https://read.qxmd.com/read/38650940/longitudinal-cytokine-and-multi-modal-health-data-of-an-extremely-severe-me-cfs-patient-with-hsd-reveals-insights-into-immunopathology-and-disease-severity
#5
JOURNAL ARTICLE
Fereshteh Jahanbani, Justin Cyril Sing, Rajan Douglas Maynard, Shaghayegh Jahanbani, Janet Dafoe, Whitney Dafoe, Nathan Jones, Kelvin J Wallace, Azuravesta Rastan, Holden T Maecker, Hannes L Röst, Michael P Snyder, Ronald W Davis
INTRODUCTION: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) presents substantial challenges in patient care due to its intricate multisystem nature, comorbidities, and global prevalence. The heterogeneity among patient populations, coupled with the absence of FDA-approved diagnostics and therapeutics, further complicates research into disease etiology and patient managment. Integrating longitudinal multi-omics data with clinical, health,textual, pharmaceutical, and nutraceutical data offers a promising avenue to address these complexities, aiding in the identification of underlying causes and providing insights into effective therapeutics and diagnostic strategies...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38649625/rosacea-in-older-adults-and-pharmacologic-treatments
#6
REVIEW
Jennifer J Lee, Anna L Chien
Rosacea is a chronic inflammatory skin condition that is often more severe in older patients. The main clinical features are erythema, telangiectasia, and inflammatory lesions of the face. The pathogenesis of this condition is not fully understood but certainly multifaceted. Immune and inflammatory dysregulation, genetics, neurogenic dysregulation, microbiome dysbiosis, and systemic disease have all been implicated in rosacea pathogenesis. As we better understand the various pathways that lead to rosacea, we acknowledge that the different symptoms may have unique underlying triggers and mechanisms...
April 23, 2024: Drugs & Aging
https://read.qxmd.com/read/38648664/association-of-lamotrigine-plasma-concentrations-with-efficacy-and-toxicity-in-patients-with-epilepsy-a-retrospective-study
#7
JOURNAL ARTICLE
Ze-Ning Lee, Merel van Nuland, Tim Bognàr, Frans S S Leijten, Kim C M van der Elst
BACKGROUND: There is limited evidence to support the currently suggested lamotrigine (LTG) therapeutic reference range of 2.5-15 mg/L for the treatment of seizures. The objective of this study was to evaluate the association of LTG plasma concentrations with the efficacy and toxicity of the treatment in patients with epilepsy. METHODS: Patients whose LTG plasma concentration was measured between January 2013 and February 2022 were included. Efficacy was defined as seizure freedom for at least 6 months around the time of measured LTG concentration...
April 18, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38648170/nutrition-micronutrients
#8
JOURNAL ARTICLE
Erin England, Cynthia Cheng
Micronutrients are nutrients the body needs in small quantities, such as vitamins and minerals. Micronutrient deficiencies can occur when an individual is restricting calorie intake for weight loss or management, not consuming an adequate amount of food to meet energy requirements due to poor appetite or illness, eliminating one or more food groups from the diet on a regular basis, or consuming a diet low in micronutrient-rich foods despite adequate or excessive energy intake. Patient groups at risk include older adults, pregnant patients, patients with alcohol use disorder, patients with vegetarian or vegan diets, and patients with increased requirements secondary to medical conditions or long-term drug use that alters nutrient absorption, metabolism, or excretion...
April 2024: FP Essentials
https://read.qxmd.com/read/38647432/understanding-the-roles-of-excipients-in-moisture-management-in-solid-dosage-forms
#9
JOURNAL ARTICLE
Natalia Veronica, Paul W S Heng, Celine V Liew
Excipients are ubiquitous in pharmaceutical products, and often, they can also play a critical role in maintaining product quality. For a product containing a moisture-sensitive drug, moisture can be deleterious to the product stability during storage. Therefore, using excipients that interact with moisture in situ can potentially alleviate product stability issues. In this study, the interactive behavior of starch with moisture was augmented by coprocessing maize starch with sodium chloride (NaCl) or magnesium nitrate hexahydrate [Mg(NO3 )2 ·6H2 O] at different concentrations (5 and 10%, w/w)...
April 22, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38647086/protox-3-0-a-webserver-for-the-prediction-of-toxicity-of-chemicals
#10
JOURNAL ARTICLE
Priyanka Banerjee, Emanuel Kemmler, Mathias Dunkel, Robert Preissner
Interaction with chemicals, present in drugs, food, environments, and consumer goods, is an integral part of our everyday life. However, depending on the amount and duration, such interactions can also result in adverse effects. With the increase in computational methods, the in silico methods can offer significant benefits to both regulatory needs and requirements for risk assessments and the pharmaceutical industry to assess the safety profile of a chemical. Here, we present ProTox 3.0, which incorporates molecular similarity and machine-learning models for the prediction of 61 toxicity endpoints such as acute toxicity, organ toxicity, clinical toxicity, molecular-initiating events (MOE), adverse outcomes (Tox21) pathways, several other toxicological endpoints and toxicity off-targets...
April 22, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38646689/impaired-kidney-function-supporting-the-safe-use-of-medicines-for-patients
#11
JOURNAL ARTICLE
Kathrine Parker, Janette Chu
Due to the increasing incidence of acute kidney injury (AKI) and chronic kidney disease (CKD), nurses in most healthcare settings are likely to care for patients with some degree of impaired kidney function. Impaired kidney function can adversely affect the way the body excretes, absorbs, distributes and metabolises medicines (pharmacokinetics), potentially resulting in a wide range of drug-related complications. This article provides an overview of the effects of impaired kidney function on pharmacokinetics and the importance of accurate drug dose adjustments for patients with related conditions...
April 22, 2024: Nursing Standard
https://read.qxmd.com/read/38646424/drug-drug-interaction-between-tacrolimus-and-caspofungin-in-chinese-kidney-transplant-patients-with-different-cyp3a5-genotypes
#12
JOURNAL ARTICLE
Yundi Zhang, Bowen Shen, Yue Li, Huiying Zong, Xiaoming Zhang, Xiaohong Cao, Fengxi Liu, Yan Li
BACKGROUND: The effect of drug-drug interaction between tacrolimus and caspofungin on the pharmacokinetics of tacrolimus in different CYP3A5 genotypes has not been reported in previous studies. OBJECTIVES: To investigate the effect of caspofungin on the blood concentration and dose of tacrolimus under different CYP3A5 genotypes. DESIGN: We conducted a retrospective cohort study in The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital from January 2015 to December 2022...
2024: Therapeutic Advances in Drug Safety
https://read.qxmd.com/read/38646228/agranulocytosis-associated-with-psychiatric-polypharmacy-lessons-learned-from-a-clinical-case
#13
Nicole Ann E Villa, Dragos G Pausescu, Eduardo D Espiridion
Psychiatric polypharmacy involves the use of two or more psychotropic medications to manage a mental and emotional condition. The prevalence of psychotropic polypharmacy has been increasing since the 1990s and has been attributed to the rise in multiple psychiatric conditions presenting in one patient. However, as the prevalence of polypharmacy increases to maximize therapeutic advantages, so does the adverse effect profile of those drugs used in combination, leading to very life-threatening effects such as agranulocytosis...
March 2024: Curēus
https://read.qxmd.com/read/38645753/switching-to-dolutegravir-lamivudine-two-drug-regimen-durability-and-virologic-outcomes-by-age-sex-and-race-in-routine-us-clinical-care
#14
JOURNAL ARTICLE
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, Cassidy E Henegar, Supriya Sarkar, Jean Van Wyk, Vani Vannappagari, Michael B Wohlfeiler, Gregory P Fusco
PURPOSE: Two-drug regimens (2DR) may address drug-drug interactions and toxicity concerns. Dolutegravir/lamivudine (DTG/3TC) 2DR was approved in the US for both treatment-naïve and treatment-experienced individuals with a viral load <50 copies/mL. This study describes real-world DTG/3TC 2DR treatment outcomes among treatment-experienced individuals, stratified by age, sex, and race. METHODS: From the OPERA® cohort, people with HIV with a viral load <50 copies/mL who switched from a commonly used three-drug regimen to DTG/3TC 2DR as per the label between April 8, 2019 and April 30, 2021 were included...
2024: HIV/AIDS: Research and Palliative Care
https://read.qxmd.com/read/38644462/evaluation-of-ornidazole-tablets-bioequivalence-in-chinese-healthy-participants-under-fasted-and-fed-conditions-using-pharmacokinetic-parameters
#15
JOURNAL ARTICLE
Yanrong Wang, Yuanyuan He, Weihong Li, Hongmin Li, Liyuan Tang, Xinya Dai, Yingzi Pei, Lijing Gao
BACKGROUND AND OBJECTIVE: Ornidazole, the third generation of nitroimidazole derivatives after metronidazole and tinidazole, it exerts both bactericidal and antiprotozoal effects. The purpose of this study was to evaluate the pharmacokinetic and bioequivalence of two ornidazole tablets manufactured by two different manufacturers based on their pharmacokinetic parameters. PATIENTS AND METHODS: Fasted and fed healthy Chinese volunteers participated in a randomized sequence, single-dose, open-label, two-period crossover trial...
April 22, 2024: Drugs in R&D
https://read.qxmd.com/read/38643561/label-free-cell-phenotypic-profiling-of-histamine-h4r-receptor-and-discovery-of-non-competitive-h4r-antagonist-from-natural-products
#16
JOURNAL ARTICLE
Hongming Tang, Tao Hou, Han Zhou, Han Liao, Fangfang Xu, Xiaomin Xie, Wenjie Yuan, Zhixin Guo, Yanfang Liu, Jixia Wang, Weijia Zhou, Xinmiao Liang
Histamine 4 receptor (H4R), the most recently identified subtype of histamine receptor, primarily induces inflammatory reactions upon activation. Several H4R antagonists have been developed for the treatment of inflammatory bowel disease (IBD) and atopic dermatitis (AD), but their use has been limited by adverse side effects, such as a short half-life and toxicity. Natural products, as an important source of anti-inflammatory agents, offer minimal side effects and reduced toxicity. This work aimed to identify novel H4R antagonists from natural products...
April 18, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38643493/antibody-drug-conjugate-adverse-effects-can-be-understood-and-addressed-based-on-immune-complex-clearance-mechanisms
#17
JOURNAL ARTICLE
Ronald P Taylor, Margaret A Lindorfer
Numerous antibody-drug conjugates (ADC) are being developed for cancer immunotherapy. Although several of these agents have demonstrated considerable clinical efficacy and have won FDA approval, in many instances they have been characterized by adverse side effects (ASE) which can be quite severe in a fraction of treated patients. The key hypothesis in this perspective is that many of the most serious ASE associated with the use of ADC in the treatment of cancer can be most readily explained and understood due to the inappropriate processing of these ADC via pathways normally followed for immune complex clearance, which include phagocytosis and trogocytosis...
April 21, 2024: Blood
https://read.qxmd.com/read/38642625/antagonistic-effects-of-a-cox1-2-inhibitor-drug-in-human-hepg2-cells-exposed-to-an-environmental-carcinogen
#18
JOURNAL ARTICLE
Carla Martins, Marcos Felipe de Oliveira Galvão, Pedro M Costa, Kristian Dreij
Understanding interactions between legacy and emerging environmental contaminants has important implications for risk assessment, especially when involving mutagens and carcinogens whose critical effects are chronic and therefore difficult to predict. The current work aimed to investigate potential interactions between benzo[a]pyrene (B[a]P), a carcinogenic polycyclic aromatic hydrocarbon and legacy pollutant, and diclofenac (DFC), a non-steroidal anti-inflammatory drugs and pollutant of emerging concern and how DFC affects B[a]P toxicity...
April 18, 2024: Environmental Toxicology and Pharmacology
https://read.qxmd.com/read/38642071/cascade-nanoreactor-employs-mitochondrial-directed-chemodynamic-and-%C3%AE-ala-mediated-photodynamic-synergy-for-deep-seated-oral-cancer-therapy
#19
JOURNAL ARTICLE
Qiqi Yin, Yanli Yao, Handan Zhang, Jie Zhang, Jiaming Gao, Lin Weng, Tao Liu, Shuyang Sun, Xin Chen
The management of oral squamous cell carcinoma (OSCC) poses significant challenges, leading to organ impairment and ineffective treatment of deep-seated tumors, adversely affecting patient prognosis. We introduced a cascade nanoreactor that integrates photodynamic therapy (PDT) and chemodynamic therapy (CDT) for comprehensive multimodal OSCC treatment. Utilizing iron oxide nanoparticles and mesoporous silica, we developed the FMMSH drug delivery system, encapsulating the photosensitizer prodrug δ-aminolevulinic acid (δ-ALA)...
April 20, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38641999/incidence-and-risk-factors-for-potential-drug-drug-interactions-in-outpatients-receiving-opioid-analgesics
#20
JOURNAL ARTICLE
Fei Chu, Yang Yao, Bei Gao, Mingzhi Huang, Lingti Kong
BACKGROUND: Opioids are the most frequently used drugs to treat pain in cancer patients. However opioid analgesics can cause adverse effects and potential drug-drug interaction. RESEARCH DESIGN AND METHODS: This cross-sectional retrospective study analyzed pDDI in 1839 patients with opioid analgesics in a large comprehensive hospital in China from January 1 to 31 December 2022. Three drug interaction databases were used to screen for pDDI including Drugs (U.S.A...
April 20, 2024: Expert Opinion on Drug Safety
keyword
keyword
112626
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.